Global and Region Angiopoietin 2 Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Angiopoietin 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Angiopoietin 2market, defines the market attractiveness level of Angiopoietin 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Angiopoietin 2 industry, describes the types of Angiopoietin 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiopoietin 2 market and the development prospects and opportunities of Angiopoietin 2 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiopoietin 2 market in Chapter 13.

    By Player:

    • Regeneron Pharmaceuticals, Inc

    • RXi Pharmaceuticals Corporation

    • Synergys Biotherapeutics, Inc

    • F Hoffmann-La Roche Ltd

    • Eli Lilly and Company

    • Amgen Inc

    • MedImmune, LLC

    • Boehringer Ingelheim GmbH

    • Silence Therapeutics Plc

    • AnGes MG, Inc

    By Type:

    • Atu-111

    • BI-836880

    • LY-3127804

    • MEDI-3617

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Angiopoietin 2 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Angiopoietin 2 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Angiopoietin 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Angiopoietin 2 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Angiopoietin 2 Market Analysis and Outlook to 2022

    • 7.1 Global Angiopoietin 2 Consumption (2017-2022)

    • 7.2 United States Angiopoietin 2 Consumption (2017-2022)

    • 7.3 Europe Angiopoietin 2 Consumption (2017-2022)

    • 7.4 China Angiopoietin 2 Consumption (2017-2022)

    • 7.5 Japan Angiopoietin 2 Consumption (2017-2022)

    • 7.6 India Angiopoietin 2 Consumption (2017-2022)

    • 7.7 South Korea Angiopoietin 2 Consumption (2017-2022)

    8 Region and Country-wise Angiopoietin 2 Market Analysis and Outlook to 2028

    • 8.1 Global Angiopoietin 2 Consumption Forecast (2022-2028)

    • 8.2 United States Angiopoietin 2 Consumption Forecast (2022-2028)

    • 8.3 Europe Angiopoietin 2 Consumption Forecast (2022-2028)

    • 8.4 China Angiopoietin 2 Consumption Forecast (2022-2028)

    • 8.5 Japan Angiopoietin 2 Consumption Forecast (2022-2028)

    • 8.6 India Angiopoietin 2 Consumption Forecast (2022-2028)

    • 8.7 South Korea Angiopoietin 2 Consumption Forecast (2022-2028)

    9 Global Angiopoietin 2 Market Outlook by Types and Applications to 2022

    • 9.1 Global Angiopoietin 2 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Atu-111 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global BI-836880 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global LY-3127804 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global MEDI-3617 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Angiopoietin 2 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Angiopoietin 2 Market Outlook by Types and Applications to 2028

    • 10.1 Global Angiopoietin 2 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Atu-111 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global BI-836880 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global LY-3127804 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global MEDI-3617 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Angiopoietin 2 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Angiopoietin 2 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Angiopoietin 2 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Angiopoietin 2 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Angiopoietin 2 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Angiopoietin 2 Market Competitive Analysis

    • 14.1 Regeneron Pharmaceuticals, Inc

      • 14.1.1 Regeneron Pharmaceuticals, Inc Company Details

      • 14.1.2 Regeneron Pharmaceuticals, Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Regeneron Pharmaceuticals, Inc Angiopoietin 2 Product and Service

    • 14.2 RXi Pharmaceuticals Corporation

      • 14.2.1 RXi Pharmaceuticals Corporation Company Details

      • 14.2.2 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Product and Service

    • 14.3 Synergys Biotherapeutics, Inc

      • 14.3.1 Synergys Biotherapeutics, Inc Company Details

      • 14.3.2 Synergys Biotherapeutics, Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Synergys Biotherapeutics, Inc Angiopoietin 2 Product and Service

    • 14.4 F Hoffmann-La Roche Ltd

      • 14.4.1 F Hoffmann-La Roche Ltd Company Details

      • 14.4.2 F Hoffmann-La Roche Ltd Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-La Roche Ltd Angiopoietin 2 Product and Service

    • 14.5 Eli Lilly and Company

      • 14.5.1 Eli Lilly and Company Company Details

      • 14.5.2 Eli Lilly and Company Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eli Lilly and Company Angiopoietin 2 Product and Service

    • 14.6 Amgen Inc

      • 14.6.1 Amgen Inc Company Details

      • 14.6.2 Amgen Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Amgen Inc Angiopoietin 2 Product and Service

    • 14.7 MedImmune, LLC

      • 14.7.1 MedImmune, LLC Company Details

      • 14.7.2 MedImmune, LLC Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 MedImmune, LLC Angiopoietin 2 Product and Service

    • 14.8 Boehringer Ingelheim GmbH

      • 14.8.1 Boehringer Ingelheim GmbH Company Details

      • 14.8.2 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boehringer Ingelheim GmbH Angiopoietin 2 Product and Service

    • 14.9 Silence Therapeutics Plc

      • 14.9.1 Silence Therapeutics Plc Company Details

      • 14.9.2 Silence Therapeutics Plc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Silence Therapeutics Plc Angiopoietin 2 Product and Service

    • 14.10 AnGes MG, Inc

      • 14.10.1 AnGes MG, Inc Company Details

      • 14.10.2 AnGes MG, Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AnGes MG, Inc Angiopoietin 2 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Angiopoietin 2

    • Figure Angiopoietin 2 Picture

    • Table Global Angiopoietin 2 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiopoietin 2 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiopoietin 2 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Angiopoietin 2 Consumption by Country (2017-2022)

    • Figure United States Angiopoietin 2 Consumption and Growth Rate (2017-2022)

    • Table Europe Angiopoietin 2 Consumption and Growth Rate (2017-2022)

    • Figure China Angiopoietin 2 Consumption and Growth Rate (2017-2022)

    • Figure Japan Angiopoietin 2 Consumption and Growth Rate (2017-2022)

    • Figure India Angiopoietin 2 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Angiopoietin 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Angiopoietin 2 Consumption Forecast by Country (2022-2028)

    • Figure United States Angiopoietin 2 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Angiopoietin 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Angiopoietin 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Angiopoietin 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Angiopoietin 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Angiopoietin 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Atu-111 Consumption and Growth Rate (2017-2022)

    • Figure Global BI-836880 Consumption and Growth Rate (2017-2022)

    • Figure Global LY-3127804 Consumption and Growth Rate (2017-2022)

    • Figure Global MEDI-3617 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Atu-111 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BI-836880 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LY-3127804 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MEDI-3617 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Angiopoietin 2 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Angiopoietin 2 Export by Region (Top 5 Countries) (2017-2028)

    • Table Regeneron Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals, Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals, Inc Angiopoietin 2 Product and Service

    • Table RXi Pharmaceuticals Corporation (Foundation Year, Company Profile and etc.)

    • Table RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table RXi Pharmaceuticals Corporation Angiopoietin 2 Product and Service

    • Table Synergys Biotherapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Synergys Biotherapeutics, Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synergys Biotherapeutics, Inc Angiopoietin 2 Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Angiopoietin 2 Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Angiopoietin 2 Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Angiopoietin 2 Product and Service

    • Table MedImmune, LLC (Foundation Year, Company Profile and etc.)

    • Table MedImmune, LLC Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune, LLC Angiopoietin 2 Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Angiopoietin 2 Product and Service

    • Table Silence Therapeutics Plc (Foundation Year, Company Profile and etc.)

    • Table Silence Therapeutics Plc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silence Therapeutics Plc Angiopoietin 2 Product and Service

    • Table AnGes MG, Inc (Foundation Year, Company Profile and etc.)

    • Table AnGes MG, Inc Angiopoietin 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table AnGes MG, Inc Angiopoietin 2 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.